PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study questions the relevance of SCIP benchmarks among CABG patients

2012-11-09
(Press-News.org) (Boston) – Cardiothoracic surgeons and endocrinologists from Boston Medical Center (BMC) have found that among patients undergoing coronary artery bypass graft (CABG) surgery, achieving Surgical Care Improvement Project (SCIP) benchmarks for glycemic control may be irrelevant when perioperative continuous insulin infusion protocols are implemented. These findings appear on-line in the Journal of Thoracic and Cardiovascular Surgery.

Currently, 40 percent of all patients undergoing CABG suffer from diabetes, and this number is quickly rising. Traditionally these patients have more complications following surgery, including greater risk of heart attacks, more wound infections and reduced long-term survival. Previous studies from BMC have shown that patients receiving insulin infusions during surgery and in the postoperative period to achieve blood glucose levels of less than 200mg/dl have significantly less morbidity and mortality. As a result of these pioneering studies, national guidelines now mandate that all CABG patients receive an intravenous insulin infusion when necessary to maintain blood glucose levels of less than 200mg/dl in the perioperative period.

SCIP has benchmarked 6 a.m. blood glucose of less than 200 mg/dl on post-operative day one and day two as a quality measure of glycemic control in cardiac surgery to be used for reporting of operative outcomes and monetary reimbursement. However, the relevance of SCIP in patients already receiving continuous insulin infusions, designed to achieve optimal glycemic control, is unknown. Hospitals in which SCIP outliers are present may be publicly cited for poor glycemic control and receive less monetary reimbursement. It is important, therefore, to determine whether SCIP is a valid marker of glycemic control in CABG patients.

Between January 2006 and April 2011, 833 patients underwent CABG surgery at BMC and received continuous insulin infusions to maintain serum blood glucose of less than 180 mg/dl. Patients were divided into two groups: patients compliant with SCIP and those who were outliers-those who fell outside of the SCIP guidelines.

The researchers found the incidence of SCIP outliers to be 6.6 percent. These patients were more likely to suffer from insulin-dependent diabetes, have a higher hemoglobin A1C level which is indicative of poor glucose control in the months preceding surgery, higher body mass and lower ejection fraction. "However, patients who were SCIP outliers had no increase in morbidity, mortality or hospital length of stay," explained senior author Harold Lazar, MD, a cardiothoracic surgeon at BMC and professor of cardiothoracic surgery at Boston University School of Medicine.

According to Lazar these findings may have national implications and may result in changes in guidelines for glycemic control. "We found that these patients may have had excellent glycemic control except for that one 6AM glucose level," added Lazar. A better index of glycemic control is to look at the percentage of time that a patients' glucose was less than 200mg/dl over 48 hours and not just one or two arbitrary points in time. "On the other hand, we saw patients who had poor glycemic control but just happened to have a glucose level of less than 200mg/dl at the two time periods measured by SCIP."

Furthermore, this study had identified groups of patients whose glucose levels are harder to control despite the fact that are continuously receiving insulin. Yet, they are still better off compared to not having received any infusions----however, they would be considered SCIP outliers and those hospitals would be penalized. "We think that glycemic control is important in ALL CABG patients----however, current SCIP guidelines are not an accurate method to determine whether hospitals are truly compliant with meeting the goals of glycemic control."

### END


ELSE PRESS RELEASES FROM THIS DATE:

Belatacept after a kidney transplant: Minor added benefit for certain patients

2012-11-09
Belatacept (trade name Nulojix®) has been approved since June 2011 to prevent a rejection reaction of the body to the donor organ (transplant) in adults who have received a kidney transplant. The Institute for Quality and Efficiency in Health Care (IQWiG) has examined the added benefit of the drug pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG). The assessment showed an indication of a minor added benefit of belatacept in adults with transplants from donors who had been selected according to the so-called standard criteria. Serious side ...

Moffitt Cancer Center researchers identify novel metabolic programs driving aggressive brain tumors

2012-11-09
Researchers at Moffitt Cancer Center have identified metabolic signatures that may pave the way for personalized therapy in glioma, a type of tumor that starts in the brain. The study appears online in the October issue of Cancer Research, a publication of the American Association for Cancer Research. According to the authors, little has been known about the underlying metabolic alterations that may drive the growth of the most aggressive type of glioma, termed glioblastoma. "For the first time, we have described global metabolomic signatures in glioma," said study ...

Considerable added benefit of ipilimumab in advanced melanoma

2012-11-09
The humanized antibody ipilimumab (trade name Yervoy®) has been approved since August 2011 for the treatment of adult patients with advanced melanoma (black skin cancer) who have already been treated. The term "advanced" means that the melanoma can no longer be removed by an operation or that metastases have formed. The German Institute for Quality and Efficiency in Health Care (IQWiG) has examined the added benefit of the drug pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG). According to the findings, the drug offers major advantages with ...

University of Huddersfield physicist investigates the Big Bang particle

2012-11-09
Scientists at the University of Huddersfield are collaborating with experts at some of the world's leading research institutes in an attempt to unravel the mysteries of a particle that played a role in the creation of the universe. The existence of neutrinos and anti-neutrinos – particles that are almost massless and which travel at light speed from one side of the earth to the other – was confirmed more than 50 years ago. Scientists believe that they were created at the Big Bang and might hold the key to the nature of the universe. But they are light particles that ...

Vandetanib in thyroid cancer: No proof of added benefit

2012-11-09
Vandetanib (trade name Caprelsa®) has been approved in Germany since February 2012 for adult patients suffering from a particular form of aggressive thyroid cancer. The German Institute for Quality and Efficiency in Health Care (IQWiG) has now examined the added benefit of the drug pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG). According to the findings, there is no proof of added benefit, because no data on patient-relevant outcomes for those patients for whom the drug is approved were presented by the drug manufacturer in its dossier. ...

UGR and Michael J. Fox Foundation take a step forward in the study of Parkinson's disease

2012-11-09
This press release is available in Spanish. During the past year, the research group TIC 218 at the Department of Signal Theory, Telematics and Communications attached to the University of Granada and the Andalusian Information Technology and Communications Center (CITIC) has implemented the methods for the detection and diagnosis of Alzheimer's disease, within the PPMI initiative of the Michael J. Fox foundation for the study of Parkinson's disease. In addition, other databases were used such as that of the Virgen de la Victoria Hospital, Málaga, Spain, and Virgen de ...

CHOP experts describe research in pediatric heart disease

2012-11-09
Physician-researchers from the Cardiac Center at The Children's Hospital of Philadelphia presented new findings on pediatric cardiovascular disease at the American Heart Association's Scientific Sessions 2012 in Los Angeles. They described racial disparities in risk factors for sudden cardiac death, imaging modalities and novel approaches to assessing cardiac anomalies, ventricular assist device use, special considerations in syndromes in adult congenital heart disease, changes in immunosuppressive drugs after pediatric heart transplant, and many other topics. Children's ...

Cool pavements, warm buildings, rising electricity bills

Cool pavements, warm buildings, rising electricity bills
2012-11-09
A push to replace old, heat-trapping paving materials with new, cooler materials could actually lead to higher electricity bills for surrounding buildings, engineers at the University of California, San Diego, have found. Researchers published their findings Oct. 29 in the new Journal of Urban Climate. The new paving materials are designed to lower the overall temperature of the areas where they are used—something that the study, which was focused on local solar radiation and energy consumption, was not designed to measure. The study sounds a note of caution at a time ...

Stem cell scientists discover potential way to expand cells for use with patients

2012-11-09
(TORONTO, Canada – Nov. 8, 2012) – Canadian and Italian stem cell researchers have discovered a new "master control gene" for human blood stem cells and found that manipulating its levels could potentially create a way to expand these cells for clinical use. The findings, published today online ahead of print in Cell Stem Cell, usher in a new paradigm for the regulation of human blood stem cells, says co-principal investigator Dr. John Dick, who holds a Canada Research Chair in Stem Cell Biology and is a Senior Scientist at University Health Network's McEwen Centre for ...

Intensive farming with a climate-friendly touch: Farming/woodland mix increases yields

Intensive farming with a climate-friendly touch: Farming/woodland mix increases yields
2012-11-09
This press release is available in Spanish and Portuguese. Each year, huge carbon stores are lost as a result of deforestation. In South America, around four million hectares of forest are cut down every year. As a result, international climate protection programs are planning to financially compensate farmers who preserve forests or plant new trees. Demand for land is rising, however. And growing need for food and energy crops will inevitably lead to conflicts of interest over fertile land in countries such as Brazil and Ecuador. Thomas Knoke and Michael Weber at Technische ...

LAST 30 PRESS RELEASES:

NHS urged to offer single pill to all over-50s to prevent heart attacks and strokes

Australian researchers call for greater diversity in genomics

The pot is already boiling for 2% of the world’s amphibians: new study

A new way to predict cancer's spread? Scientists look at 'stickiness' of tumor cells

Prehistoric bone tool ‘factory’ hints at early development of abstract reasoning in human ancestors

Study: Vaping does not help US tobacco smokers quit

Insect populations are declining — and that is not a good thing

Scientists discover genes to grow bigger tomatoes and eggplants

Effects of combining coronary calcium score with treatment on plaque progression in familial coronary artery disease

Cancer screening 3 years after the onset of the COVID-19 pandemic

Trajectories of sleep duration, sleep onset timing, and continuous glucose monitoring in adults

Sports gambling and drinking behaviors over time

For better quantum sensing, go with the flow

Toxic environmental pollutants linked to faster aging and health risks in US adults

Jerome Morris voted AERA President-Elect; key members elected to AERA Council

Study reveals how agave plants survive extreme droughts

Aligning Science Across Parkinson’s (ASAP) launches a second funding opportunity to accelerate novel tool development to advance Parkinson's disease research

New study: Eating mangos daily shown to improve insulin sensitivity and blood glucose control

Highly radioactive nuclear waste – how to keep it from oblivion

Generations ‘sync’ up in rural ‘glades’ to boost technology use for health

Unveiling the mechanism of maintenance of replication and transcription in mitochondria

Pioneering research into brain cancer is awarded the world’s largest brain research prize, The Brain Prize

Concrete evidence: Japanese buildings absorb 14% of cement production's carbon footprint

New study examines how physics students perceive recognition

For some, childhood adversity can promote resilience to anxiety disorders

A sustainable iron catalyst for water oxidation in renewable energy

Cloud–radiation feedbacks found to be key to the diverse tropical pacific warming projections

Body image perceptions take shape from early childhood, psychologists reveal

Can long-term use of anti-inflammatory medications prevent dementia?

Review supports introducing small amounts of food allergens during early childhood

[Press-News.org] Study questions the relevance of SCIP benchmarks among CABG patients